Ewelina Kulikowski

8PUBLICATIONS
4CO-AUTHORS
Medical biochemistry - lipidsMolecular targetsPredictive and prognostic markersMedical molecular engineering of nucleic acids and proteinsCardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 28, 2026
Apabetalone Drives a Metabolic Shift Towards Ketogenesis and Reduces Liver Steatosis in Diet-Induced Obesity Mice.

|Oct 28, 2023
Apabetalone, a Clinical-Stage, Selective BET Inhibitor, Opposes DUX4 Target Gene Expression in Primary Human FSHD Muscle Cells.

Christopher D Sarsons, Dean Gilham, Laura M Tsujikawa

|Jun 28, 2023
Apabetalone Downregulates Fibrotic, Inflammatory and Calcific Processes in Renal Mesangial Cells and Patients with Renal Impairment.

Dean Gilham, Sylwia Wasiak, Brooke D Rakai

|Nov 11, 2020
BET protein inhibitor apabetalone (RVX-208) suppresses pro-inflammatory hyper-activation of monocytes from patients with cardiovascular disease and type 2 diabetes.

Sylwia Wasiak, Kim E Dzobo, Brooke D Rakai

|Sep 14, 2020
Inhibitors of bromodomain and extra-terminal proteins for treating multiple human diseases.

Ewelina Kulikowski, Brooke D Rakai, Norman C W Wong

|Aug 22, 2020
Epigenetic Modulation by Apabetalone Counters Cytokine-Driven Acute Phase Response In Vitro, in Mice and in Patients with Cardiovascular Disease.

Sylwia Wasiak, Dean Gilham, Emily Daze

Pageof 2

Frequent Collaborators

2 joint publications

Dean Gilham

1 joint publications

Brooke D Rakai

1 joint publications

Li Fu

1 joint publications

Ravi Jahagirdar